» Articles » PMID: 7078891

Estrogen Levels in Postmenopausal Women with Hot Flashes

Overview
Journal Obstet Gynecol
Date 1982 Apr 1
PMID 7078891
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Following menopause, some women are troubled by hot flashes (episodes of flushing and perspiration), whereas others do not experience the symptom. To determine whether the extent of estrogen deficiency influences the occurrence of the disturbance, the authors measured the levels of estradiol (E2), estrone (E1), and sex-hormone binding globulin (SHBG), and the percent and total non-SHBG-bound E2 in 24 women with frequent hot flashes and 24 women who had never experienced the symptom. Significantly lower levels of E2 (P less than .002), E1 (P less than .05), percent non-SHBG E2 (P less than .05), and total non-SHBG-bound E2 (P less than .01) were found in the symptomatic women. Similar differences were confirmed in 18 subject pairs matched for age, years since menopause, and presence or absence of ovaries. The finding of a significantly (P less than .05) lower percent ideal body weight in the women with hot flashes suggests that the known effects of body weight on the rate of extraglandular estrogen production and the level of SHBG in postmenopausal women may be important variables determining the occurrence of hot flashes.

Citing Articles

The relationship between hot flashes and fatty acid binding protein 2 in postmenopausal women.

Chen T, Huang W, Liu K, Kor C, Chao Y, Wu H PLoS One. 2022; 17(10):e0276391.

PMID: 36260646 PMC: 9581385. DOI: 10.1371/journal.pone.0276391.


Metabolically healthy and unhealthy obesity and risk of vasomotor symptoms in premenopausal women: cross-sectional and cohort studies.

Namgoung S, Chang Y, Woo C, Kim Y, Kang J, Kwon R BJOG. 2022; 129(11):1926-1934.

PMID: 35596933 PMC: 9541406. DOI: 10.1111/1471-0528.17224.


The relationship of menopausal symptoms with the type of menopause and lipid levels.

Demir O, Ozalp M, Sal H, Aran T, Osmanagaoglu M Prz Menopauzalny. 2020; 19(1):6-10.

PMID: 32508550 PMC: 7258375. DOI: 10.5114/pm.2020.95300.


Symptomatic menopausal transition and risk of subsequent stroke.

Yu C, Kor C, Weng S, Chang C, Chen C, Wu C PeerJ. 2019; 7:e7964.

PMID: 31687279 PMC: 6825412. DOI: 10.7717/peerj.7964.


Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

Wang Y, Hernandez G, Mack W, Schneider L, Yin F, Brinton R Menopause. 2019; 27(1):57-65.

PMID: 31567873 PMC: 7100617. DOI: 10.1097/GME.0000000000001418.